{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:31:59Z","timestamp":1740123119278,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"crossref","award":["004_94482"],"award-info":[{"award-number":["004_94482"]}],"id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11033-020-05985-4","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T16:02:56Z","timestamp":1605628976000},"page":"9967-9972","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The clinical and genetic features of hereditary haemorrhagic telangiectasia (HHT) in central South Africa\u2014three novel pathogenic variants"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4775-4793","authenticated-orcid":false,"given":"Tendaishe T.","family":"Mutize","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9774-334X","authenticated-orcid":false,"given":"Riaz Y.","family":"Seedat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9622-3994","authenticated-orcid":false,"given":"Johannes K.","family":"Ploos van Amstel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes J.","family":"Mager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8508-8667","authenticated-orcid":false,"given":"Stephen C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-0255","authenticated-orcid":false,"given":"Fekade","family":"Gebremariam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2762-0966","authenticated-orcid":false,"given":"Marius J.","family":"Coetzee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"5985_CR1","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1443","author":"ME Faughnan","year":"2020","unstructured":"Faughnan ME, Mager JJ, Hetts SW et al (2020) Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. https:\/\/doi.org\/10.7326\/M20-1443","journal-title":"Ann Intern Med"},{"issue":"2","key":"5985_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/jmg.2009.069013","volume":"48","author":"ME Faughnan","year":"2011","unstructured":"Faughnan ME, Palda VA, Garcia-Tsao G et al (2011) International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 48(2):73\u201387. https:\/\/doi.org\/10.1136\/jmg.2009.069013","journal-title":"J Med Genet"},{"issue":"1","key":"5985_CR3","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1111\/j.1365-2516.2010.02353.x","volume":"17","author":"CJ Westermann","year":"2011","unstructured":"Westermann CJ, Kitonyi GW, Letteboer TG (2011) Is hereditary haemorrhagic telangiectasia rare in the black race? The first sub-Saharan mutation. Haemophilia 17(1):e244-2516. https:\/\/doi.org\/10.1111\/j.1365-2516.2010.02353.x","journal-title":"Haemophilia"},{"issue":"27","key":"5985_CR4","first-page":"557","volume":"27","author":"AM Theron","year":"1953","unstructured":"Theron AM (1953) Hereditary haemorrhagic telangiectasia\u2014report of a Bantu case. S Afr Med J 27(27):557\u2013559","journal-title":"S Afr Med J"},{"issue":"8","key":"5985_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.4314\/eamj.v85i8.9659","volume":"85","author":"GW Kitonyi","year":"2008","unstructured":"Kitonyi GW, Wambugu PM, Oburra HO, Ireri JM (2008) Hereditary haemorrhagic telangiectasia in a black adult male: case report. East Afr Med J 85(8):412\u2013416","journal-title":"East Afr Med J"},{"issue":"1","key":"5985_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13256-016-0909-4","volume":"10","author":"JC Kiyeng","year":"2016","unstructured":"Kiyeng JC, Siika A, Koech C, Bloomfield GS (2016) Definite hereditary hemorrhagic telangiectasia in a 60-year-old black Kenyan woman: a case report. J Med Case Rep 10(1):126. https:\/\/doi.org\/10.1186\/s13256-016-0909-4","journal-title":"J Med Case Rep"},{"issue":"3","key":"5985_CR7","first-page":"363","volume":"35","author":"AE Jaiyesimi","year":"1989","unstructured":"Jaiyesimi AE, Mba EC (1989) Hereditary haemorrhagic telangiectasia in Nigeria: case report. Cent Afr J Med 35(3):363\u2013365","journal-title":"Cent Afr J Med"},{"issue":"4","key":"5985_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.7196\/samj.7816","volume":"104","author":"C Canzonieri","year":"2014","unstructured":"Canzonieri C, Ornati F, Matti E et al (2014) Hereditary haemorrhagic telangiectasia in North African and sub-Saharan patients. S Afr Med J 104(4):256\u2013257. https:\/\/doi.org\/10.7196\/samj.7816","journal-title":"S Afr Med J"},{"key":"5985_CR9","unstructured":"Westermann CJJ (1994) HHT in people of African descent. vol 9:1. HHT Foundation International (now cureHHT), New Haven, CT, USA"},{"issue":"4","key":"5985_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/ajmg.a.10002","volume":"116a","author":"CJ Westermann","year":"2003","unstructured":"Westermann CJ, Rosina AF, De Vries V, de Coteau PA (2003) The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screening. Am J Med Genet A 116a(4):324\u2013328. https:\/\/doi.org\/10.1002\/ajmg.a.10002","journal-title":"Am J Med Genet A"},{"key":"5985_CR11","first-page":"917","volume":"38","author":"I Kennedy","year":"1964","unstructured":"Kennedy I (1964) Hereditary telangiectasia in a Zulu family. S Afr Med J 38:917\u2013917","journal-title":"S Afr Med J"},{"issue":"1","key":"5985_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E et al (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91(1):66\u201367. https:\/\/doi.org\/10.1002\/(SICI)1096-8628(20000306)91:1%3c66::AID-AJMG12%3e3.0.CO;2-P","journal-title":"Am J Med Genet"},{"issue":"4","key":"5985_CR13","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/lary.20818","volume":"120","author":"JB Hoag","year":"2010","unstructured":"Hoag JB, Terry P, Mitchell S et al (2010) An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope 120(4):838\u2013843. https:\/\/doi.org\/10.1002\/lary.20818","journal-title":"Laryngoscope"},{"issue":"9","key":"5985_CR14","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1478-3231.2006.01340.x","volume":"26","author":"E Buscarini","year":"2006","unstructured":"Buscarini E, Plauchu H, Garcia Tsao G et al (2006) Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations. Liver Int 26(9):1040\u20131046. https:\/\/doi.org\/10.1111\/j.1478-3231.2006.01340.x","journal-title":"Liver Int"},{"issue":"1","key":"5985_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00439-004-1196-5","volume":"116","author":"TGW Letteboer","year":"2005","unstructured":"Letteboer TGW, Zewald RA, Kamping EJ et al (2005) Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients. Hum Genet 116(1):8\u201316. https:\/\/doi.org\/10.1007\/s00439-004-1196-5","journal-title":"Hum Genet"},{"issue":"5","key":"5985_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, on behalf of the ALQAC et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"1","key":"5985_CR17","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1038\/s41467-017-00663-9","volume":"8","author":"A Choudhury","year":"2017","unstructured":"Choudhury A, Ramsay M, Hazelhurst S et al (2017) Whole-genome sequencing for an enhanced understanding of genetic variation among South Africans. Nat Commun 8(1):2062. https:\/\/doi.org\/10.1038\/s41467-017-00663-9","journal-title":"Nat Commun"},{"issue":"1","key":"5985_CR18","doi-asserted-by":"publisher","first-page":"0746","DOI":"10.1186\/s12915-020-0746-1","volume":"18","author":"N Hollfelder","year":"2020","unstructured":"Hollfelder N, Erasmus JC, Hammaren R et al (2020) Patterns of African and Asian admixture in the Afrikaner population of South Africa. BMC Biol 18(1):0746. https:\/\/doi.org\/10.1186\/s12915-020-0746-1","journal-title":"BMC Biol"},{"issue":"4","key":"5985_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1399-0004.2010.01596.x","volume":"79","author":"J McDonald","year":"2011","unstructured":"McDonald J, Damjanovich K, Millson A et al (2011) Molecular diagnosis in hereditary hemorrhagic telangiectasia: findings in a series tested simultaneously by sequencing and deletion\/duplication analysis. Clin Genet 79(4):335\u2013344. https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01596.x","journal-title":"Clin Genet"},{"issue":"4","key":"5985_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/humu.20017","volume":"23","author":"G Lesca","year":"2004","unstructured":"Lesca G, Plauchu H, Coulet F et al (2004) Molecular screening of ALK1\/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France. Hum Mutat 23(4):289\u2013299. https:\/\/doi.org\/10.1002\/humu.20017","journal-title":"Hum Mutat"},{"issue":"4","key":"5985_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/sj.ejhg.5200919","volume":"11","author":"SA Abdalla","year":"2003","unstructured":"Abdalla SA, Cymerman U, Johnson RM et al (2003) Disease-associated mutations in conserved residues of ALK-1 kinase domain. Eur J Hum Genet 11(4):279\u2013287. https:\/\/doi.org\/10.1038\/sj.ejhg.5200919","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"5985_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/jmg.40.12.865","volume":"40","author":"RE Harrison","year":"2003","unstructured":"Harrison RE, Flanagan JA, Sankelo M et al (2003) Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J Med Genet 40(12):865\u2013871. https:\/\/doi.org\/10.1136\/jmg.40.12.865","journal-title":"J Med Genet"},{"issue":"2","key":"5985_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ng0696-189","volume":"13","author":"DW Johnson","year":"1996","unstructured":"Johnson DW, Berg JN, Baldwin MA et al (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13(2):189\u2013195. https:\/\/doi.org\/10.1038\/ng0696-189","journal-title":"Nat Genet"},{"issue":"12","key":"5985_CR24","first-page":"817","volume":"100","author":"WD Lin","year":"2001","unstructured":"Lin WD, Wu JY, Hsu HB et al (2001) Mutation analysis of a family with hereditary hemorrhagic telangiectasia associated with hepatic arteriovenous malformation. J Formos Med Assoc 100(12):817\u2013819","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"5985_CR25","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ajhg.2019.09.010","volume":"105","author":"DA Snellings","year":"2019","unstructured":"Snellings DA, Gallione CJ, Clark DS et al (2019) Somatic mutations in vascular malformations of hereditary hemorrhagic telangiectasia result in Bi-allelic loss of ENG or ACVRL1. Am J Hum Genet 105(5):894\u2013906. https:\/\/doi.org\/10.1016\/j.ajhg.2019.09.010","journal-title":"Am J Hum Genet"},{"issue":"2","key":"5985_CR26","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1016\/j.jvir.2014.12.306","volume":"26","author":"AC Jordan","year":"2015","unstructured":"Jordan AC, Meek JC, Kanaan A et al (2015) Novel pharmacological therapy for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia. J Vasc Interv Radiol 26(2):S114. https:\/\/doi.org\/10.1016\/j.jvir.2014.12.306","journal-title":"J Vasc Interv Radiol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05985-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-020-05985-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05985-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T10:18:45Z","timestamp":1607422725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-020-05985-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5985"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05985-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"10 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Research Ethics Committee of the Faculty of Health Sciences, University of the Free State (UFS-HSD2018\/1584\/2805), the Provincial Department of Health of the Free State (FS_201903_010) and the Provincial Department of Health of the Northern Cape (NC_201903_001) granted ethics approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants and the parents or legal guardians of minors gave written informed consent for their clinical and genetic details to be published.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Written informed consent was obtained from all participants who were 18\u00a0years and older, as well as from the parents or legal guardians of those younger than 18. Written assent was also obtained from participants younger than 18\u00a0years.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}